OPKO HEALTH INC. |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
Chart calendar Opko Health Inc.
eb43242caab5243657dd4d5f42f88b9f.f5DcW28PmdtJDxUWm0lmtYKi-UUQ1cntWQD9w0ADtBA.MsCsLjs7_rcqaFxe7Dge3q_KlSRKgp2kdHCvsSlExmJPwKRpDGmqoR92XA~55a1cc6c604e00eaa265b49192d23e75
Upcoming events on Opko Health Inc.
Past events on Opko Health Inc.
| 2024-03-28 11:30 am | Annual General Meeting |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-06 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-06 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-03 10:00 am | American Society of Nephrology Kidney Conference - Poster No: FR-PO972 |
| 2023-11-03 10:00 am | American Society of Nephrology Kidney Conference - Poster No: FR-PO319 |
| 2023-09-13 | Barrington Virtual Fall Investor Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-22 10:00 am | Annual General Meeting |
| 2023-05-03 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-03 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-20 04:00 pm | R&D Day |
| 2023-02-23 04:30 pm | FY 2022 Earnings Call |
| 2023-02-23 04:05 pm | FY 2022 Earnings Release |
| 2023-01-11 07:30 pm | JP Morgan Healthcare Conference |
| 2022-11-08 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-07 | Q3 2022 Earnings Release After hours |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 902 894 0.91% | 1 435 1 380 4.04% | 1 775 1 703 4.2% | 1 004 987 1.76% | 864 859 0.51% | 745 |
|
EBITDA Million USD | Released Forecast Spread | -132 -127 -3.62% | 110 113 -2.65% | 35,8 0,00 - | -158 -170 6.88% | -72,0 -64,9 -10.94% | -70,4 |
|
EBIT Million USD | Released Forecast Spread | -274 -216 -26.74% | 57,7 35,4 63.07% | 18,7 73,6 -74.6% | -226 -259 12.5% | -157 -155 -0.99% | -241 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -305 -250 -21.98% | 48,7 22,5 116.24% | -14,0 40,6 -134.51% | -392 -356 -10.07% | -184 -187 1.44% | -257 |
|
Net income Million USD | Released Forecast Spread | -315 -257 -22.58% | 30,6 24,9 22.9% | -30,1 31,4 -195.82% | -328 -318 -3.25% | -189 -196 3.87% | -259 |
|
EPS USD | Released Forecast Spread | -0,53 -0,44 -21.56% | 0,05 0,04 33.33% | -0,05 0,04 -213.64% | -0,46 -0,44 -4.15% | -0,25 -0,26 3.85% | -0,37 |
| Announcement Date | 26/02/20 | 18/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 401 317 26.49% | 329 331 -0.68% | 310 327 -5.19% | 180 184 -2.08% | 185 168 10.22% | 238 193 22.88% | 265 202 31.41% | 179 175 2.19% | 182 178 2.46% | 183 | 187 | 186 | 189 | 193 |
|
EBITDA Million USD | Released Forecast Spread | -50,7 | -50,5 -27,5 -83.64% | -3,10 -17,0 81.76% | -67,2 -20,1 -234.33% | -37,5 -48,0 21.88% | -9,00 -33,5 73.13% | 28,5 -24,3 217.28% | -44,0 -36,4 -20.88% | -47,6 -40,3 -18.11% | -26,8 | -19,3 | -15,3 | -9,00 | |
|
EBIT Million USD | Released Forecast Spread | -63,1 -8,25 -664.85% | -72,4 -33,2 -117.86% | -10,7 10,2 -205.1% | -87,8 -57,6 -52.31% | -55,3 -87,5 36.77% | -30,6 -53,3 42.6% | 7,00 -46,1 115.2% | -64,4 -69,0 6.64% | -69,1 -67,5 -2.4% | -65,3 | -62,1 | -58,7 | -54,5 | -45,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -65,8 -11,2 -486% | -76,6 -35,0 -118.64% | -86,3 21,9 -493.56% | -126 -61,8 -104.59% | -102 -88,9 -14.91% | -17,0 -60,7 71.98% | -16,5 -54,3 69.6% | -78,4 -76,9 -1.93% | -72,5 -74,7 2.92% | -66,8 | -66,3 | -64,1 | -58,9 | -47,5 |
|
Net income Million USD | Released Forecast Spread | -73,8 -12,2 -505.97% | -55,4 -35,3 -57.05% | -102 19,8 -613.88% | -86,1 -62,2 -38.33% | -85,2 -86,0 0.94% | -18,3 -57,8 68.35% | -19,6 -54,5 64.04% | -84,5 -75,5 -11.93% | -66,5 -73,5 9.51% | -67,2 | -66,5 | -64,6 | -59,3 | -47,3 |
|
EPS USD | Released Forecast Spread | -0,11 -0,02 -450% | -0,08 -0,06 -42.86% | -0,14 0,03 -660% | -0,11 -0,08 -30.95% | -0,11 -0,11 1.5% | -0,02 -0,08 73.91% | -0,03 -0,07 58.14% | -0,11 -0,10 -10% | -0,09 -0,10 10% | -0,10 | -0,10 | -0,09 | -0,08 | -0,07 |
| Announcement Date | 24/02/22 | 09/05/22 | 04/08/22 | 08/11/22 | 23/02/23 | 03/05/23 | 03/08/23 | 06/11/23 | 27/02/24 | - | - | - | - | - |
| 2024-04-28 | SMO CLINPLUS CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | NEOGENOMICS, INC.: Q1 2024 Earnings Release |
| 2024-05-03 07:00 am | FULGENT GENETICS, INC.: Q1 2024 Earnings Release |
| 2024-05-05 | OPKO HEALTH, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 | RADNET, INC.: Q1 2024 Earnings Release |
| 2024-05-07 | SYNLAB AG: Q1 2024 Earnings Release |
| 2024-05-08 | FLEURY S.A.: Q1 2024 Earnings Release |
| 2024-05-09 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
| 2024-05-09 | BML, INC.: Q4 2023 Earnings Release |
| 2024-05-09 | GC CELL CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Opko Health Inc.
- Stock Market
- Equities
- OPK Stock
- Stock
- Calendar Opko Health Inc.
